C07K 2319/00
Fusion polypeptide
C07K2319/00 (Fusion polypeptide) appears on 27,878 US grants and 44,199 published applications in this corpus.
Search patents in C07K- Granted patents
- 27,878
- Published applications
- 44,199
- Assignees
- 9,480
- Inventors
- 58,778
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1982 | 5 | 0 |
| 1983 | 3 | 0 |
| 1984 | 4 | 0 |
| 1985 | 4 | 0 |
| 1986 | 13 | 0 |
| 1987 | 26 | 0 |
| 1988 | 34 | 0 |
| 1989 | 46 | 0 |
| 1990 | 49 | 0 |
| 1991 | 71 | 0 |
| 1992 | 111 | 0 |
| 1993 | 137 | 0 |
| 1994 | 137 | 0 |
| 1995 | 151 | 0 |
| 1996 | 280 | 0 |
| 1997 | 468 | 0 |
| 1998 | 770 | 0 |
| 1999 | 834 | 0 |
| 2000 | 711 | 0 |
| 2001 | 732 | 131 |
| 2002 | 652 | 1224 |
| 2003 | 632 | 2904 |
| 2004 | 543 | 1330 |
| 2005 | 488 | 1258 |
| 2006 | 694 | 1083 |
| 2007 | 824 | 1014 |
| 2008 | 713 | 915 |
| 2009 | 676 | 1208 |
| 2010 | 732 | 1154 |
| 2011 | 695 | 1165 |
| 2012 | 649 | 1068 |
| 2013 | 723 | 1160 |
| 2014 | 814 | 1266 |
| 2015 | 805 | 1369 |
| 2016 | 937 | 1736 |
| 2017 | 1008 | 1692 |
| 2018 | 1098 | 1951 |
| 2019 | 1216 | 2110 |
| 2020 | 1359 | 2336 |
| 2021 | 1431 | 2682 |
| 2022 | 1381 | 2926 |
| 2023 | 1271 | 2785 |
| 2024 | 1459 | 3089 |
| 2025 | 1516 | 2632 |
| 2026 | 976 | 2011 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C07K 2319/01Containing a localisation/targetting motifIndexing code7,663
- C07K 2319/30Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or fc region, orIndexing code5,710
- C07K 2319/70Containing domain for protein-protein interactionIndexing code3,471
- C07K 2319/33Fusions for targeting to specific cell typesIndexing code2,334
- C07K 2319/20Containing a tag with affinity for a non-protein ligandIndexing code2,309
- C07K 2319/40Containing a tag for immunodetection, or an epitope for immunisationIndexing code2,111
- C07K 2319/50Containing protease siteIndexing code1,386
- C07K 2319/80Containing a dna binding domainIndexing code946
All 17 subgroupsShow fewer
- C07K 2319/60Containing spectroscopic/fluorescent detectionIndexing code939
- C07K 2319/55Containing a fusion with a toxinIndexing code906
- C07K 2319/31Fusions, other than fc, for prolonged plasma lifeIndexing code898
- C07K 2319/32Fusions with soluble part of a cell surface receptor, "decoy receptors"Indexing code723
- C07K 2319/61Containing an enzyme fusion for detectionIndexing code530
- C07K 2319/35Containing a fusion for enhanced stability/folding during expressionIndexing code397
- C07K 2319/90Containing a motif for post-translational modificationIndexing code340
- C07K 2319/95Containing a motif/fusion for degradationIndexing code220
- C07K 2319/85Containing an rna binding domainIndexing code134
Recent patents
- Bispecific chimeric antigen receptors targeting CD20 and BCMA6 Oct 2026US 12,751,973 B2Abelzeta Inc.
- Non-viral transcription activation domains and methods and uses related thereto6 Oct 2026US 12,753,212 B2Teknologian tutkimuskeskus VTT Oy
- Polypeptide exhibiting fluorescent properties and use for same6 Oct 2026US 12,753,213 B2Riken
- IL-10 muteins6 Oct 2026US 12,753,217 B2Universite De Lille
- Dual CAR expressing T cells individually linked to CD28 and 4-1BB6 Oct 2026US 12,753,218 B2The Trustees of the University of Pennsylvania
- Active loading of biomolecular cargo into engineered vesicles8 Oct 2026US 2026/0306415 A1Northwestern University
- Fgf21 compound / glp-1r agonist combinations with optimized activity ratio8 Oct 2026US 2026/0306587 A1Sanofi
- Compositions and methods for generating immunity to bacterial infection8 Oct 2026US 2026/0306601 A1Syntiron LLC
- Influenza estem immunogens8 Oct 2026US 2026/0306612 A1
- Prefusion-stabilized human parainfluenza virus 3 f proteins8 Oct 2026US 2026/0306613 A1Board of Regents, The University of Texas System
Most cited
By later US patents
- Recombinant immunoglobin preparations4,785US 4,816,567 AGenentech, Inc. · 1989
- Humanized immunoglobulins2,884US 5,585,089 AProtein Design Labs, Inc. · 1996
- Single polypeptide chain binding molecules2,454US 4,946,778 AGenex Corporation · 1990
- Humanized immunoglobulins2,259US 5,530,101 AProtein Design Labs, Inc. · 1996
- Humanized immunoglobulins2,030US 5,693,762 AProtein Design Labs, Inc. · 1997